tiprankstipranks
Trending News
More News >
3D Medicines, Inc. (HK:1244)
:1244
Hong Kong Market

3D Medicines, Inc. (1244) Financial Statements

Compare
2 Followers

3D Medicines, Inc. Financial Overview

3D Medicines, Inc.'s market cap is currently HK$1.55B. The company's EPS TTM is HK$-0.392; its P/E ratio is -8.09; 3D Medicines, Inc. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 445.65M¥ 634.95M¥ 567.39M¥ 60.26M¥ 0.00
Gross Profit¥ 371.74M¥ 524.01M¥ 525.18M¥ 55.98M¥ 0.00
Operating Income¥ -123.43M¥ -497.25M¥ -386.17M¥ -516.25M¥ -304.50M
EBITDA¥ -226.95M¥ -529.23M¥ -1.03B¥ -1.45B¥ -303.35M
Net Income¥ -182.66M¥ -524.70M¥ -1.02B¥ -1.43B¥ -635.38M
Balance Sheet
Cash & Short-Term Investments¥ 840.98M¥ 996.58M¥ 942.03M¥ 824.48M¥ 414.26M
Total Assets¥ 1.22B¥ 1.43B¥ 1.33B¥ 1.06B¥ 496.22M
Total Debt¥ 237.62M¥ 282.43M¥ 175.70M¥ 3.15B¥ 1.67B
Net Debt¥ -206.70M¥ -384.05M¥ -521.04M¥ 2.38B¥ -393.89M
Total Liabilities¥ 512.54M¥ 558.20M¥ 436.65M¥ 3.33B¥ 1.77B
Stockholders' Equity¥ 785.06M¥ 936.74M¥ 943.00M¥ -2.24B¥ -1.27B
Cash Flow
Free Cash Flow¥ -249.60M¥ -150.74M¥ -332.76M¥ -433.46M¥ -289.48M
Operating Cash Flow¥ -210.58M¥ -144.41M¥ -278.78M¥ -377.08M¥ -278.33M
Investing Cash Flow¥ 17.95M¥ -187.58M¥ -242.11M¥ -98.87M¥ -20.48M
Financing Cash Flow¥ -33.92M¥ 304.51M¥ 408.41M¥ 840.08M¥ 607.39M
Currency in CNY

3D Medicines, Inc. Earnings and Revenue History

3D Medicines, Inc. Debt to Assets

3D Medicines, Inc. Cash Flow

3D Medicines, Inc. Forecast EPS vs Actual EPS